Assignment and pH dependence of the19F-NMR resonances from the fluorouracil anabolites involved in fluoropyrimidine chemotherapy
- 29 June 1999
- journal article
- research article
- Published by Wiley in NMR in Biomedicine
- Vol. 12 (4) , 237-248
- https://doi.org/10.1002/(sici)1099-1492(199906)12:4<237::aid-nbm565>3.0.co;2-0
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Proton-decoupled19F spectroscopy of 5-FU catabolites in human liverMagnetic Resonance in Medicine, 1997
- Simultaneous 3D NMR spectroscopy of proton-decoupled fluorine and phosphorus in human liver during 5-fluorouracil chemotherapyMagnetic Resonance in Medicine, 1997
- Drug monitoring of 5-fluorouracil: In vivo 19F NMR study during 5-FU chemotherapy in patients with metastases of colorectal adenocarcinomaMagnetic Resonance Imaging, 1994
- Association of intratumoral pharmacokinetics of fluorouracil with clinical responseThe Lancet, 1994
- The non-invasive monitoring of low dose, infusional 5-fluorouracil and its modulation by interferon-α using in vivo 19F magnetic resonance spectroscopy in patients with colorectal cancer: A pilot studyAnnals of Oncology, 1993
- Magnetic resonance spectroscopy: a powerful tool for drug metabolism studiesBiochimie, 1992
- Biochemical pharmacology and analysis of fluoropyrimidines alone and in combination with modulatorsPharmacology & Therapeutics, 1991
- Tumor trapping of 5-fluorouracil: in vivo 19F NMR spectroscopic pharmacokinetics in tumor-bearing humans and rabbits.Proceedings of the National Academy of Sciences, 1990
- Metabolism of pyrimidine analogues and their nucleosidesPharmacology & Therapeutics, 1990
- 19F MRS studies of fluoropyrimidine chemotherapy. A reviewNMR in Biomedicine, 1989